ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Neurology

Top Neurology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GAVIN AWERBUCH MD PLLC MD

Neurology

23,726

$7.6M

707
94 are 65+

41%
patients receiving schedule two controlled substances

Avg: 3%

49%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$320
Average prescription price

Avg: $293

NAEL TARAKJI M.D.

Neurology

9,633

$1.34M

734
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $293

LAWRENCE KONST DO

Neurology

8,528

$1.36M

529
80 are 65+

40%
patients receiving schedule two controlled substances

Avg: 3%

62%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$159
Average prescription price

Avg: $293

WEIGUO ZHAO M.D.

Neurology

7,608

$1.23M

371
138 are 65+

35%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$161
Average prescription price

Avg: $293

RAO VALLABHANENI MD

Neurology

6,885

$972K

451
33 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $293

RAM GARG MD

Neurology

6,809

$1.54M

418
160 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$225
Average prescription price

Avg: $293

TIMOTHY THOITS MD

Neurology

6,765

$2.34M

765
513 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$347
Average prescription price

Avg: $293

DEMIAN NAGUIB M.D.

Neurology

6,211

$740K

459
160 are 65+

45%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $293

JAMES VOCI MD

Neurology

5,353

$1.67M

634
331 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$312
Average prescription price

Avg: $293

BHARAT TOLIA MD

Neurology

5,307

$671K

242
62 are 65+

36%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $293

GARY GURDEN MD

Neurology

5,035

$1.37M

685
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 24%

$272
Average prescription price

Avg: $293

GREGORY BARKLEY M.D.

Neurology

4,922

$515K

241
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $293

THOMAS GIANCARLO DO

Neurology

4,752

$1.22M

623
200 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$256
Average prescription price

Avg: $293

DONALD ROTH M.D.

Neurology

4,566

$1.34M

426
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$294
Average prescription price

Avg: $293

JAMES GRAMPRIE M.D.

Neurology

4,381

$603K

323
225 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $293

JORGE GONZALEZ M.D.

Neurology

4,339

$1.53M

429
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$352
Average prescription price

Avg: $293

FAYYAZ MAHMOOD MD

Neurology

4,279

$1.27M

383
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$296
Average prescription price

Avg: $293

JOANNA KALA MD

Neurology

4,272

$690K

368
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $293

ASHRAF MOHAMED M.D.

Neurology

4,217

$313K

291
80 are 65+

46%
patients receiving schedule two controlled substances

Avg: 3%

64%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $293

DAVID BURDETTE MD

Neurology

4,205

$1.05M

248
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$249
Average prescription price

Avg: $293

HARANATH POLICHERLA M.D.

Neurology

4,175

$447K

226
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

56%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $293

WILLIAM LEUCHTER M.D.

Neurology

4,167

$1.41M

628
468 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$339
Average prescription price

Avg: $293

MOHAMMAD SABBAGH M.D.

Neurology

4,127

$907K

410
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $293

ANTHONY EMMER D.O.

Neurology

3,817

$846K

434
329 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$222
Average prescription price

Avg: $293

THOMAS DUNNE MD

Neurology

3,791

$1.44M

318
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$379
Average prescription price

Avg: $293

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank